02 June 2020
HealthDay Reports: Trump-Touted Hydroxychloroquine in Short Supply for Lupus Patients
A new survey finds that more than one-third of U.S. lupus patients who take hydroxychloroquine have struggled to fill prescriptions for the drug during the COVID-19 crisis.
Trump-Touted Hydroxychloroquine in Short Supply for Lupus Patients
TUESDAY, June 2, 2020 (HealthDay News) -- A drug championed by President Donald Trump as a coronavirus panacea appears to be in short supply for people who really need it: lupus patients.
More than one-third of U.S. lupus patients who take hydroxychloroquine have struggled to fill prescriptions for the drug during the COVID-19 crisis, a new survey finds.
One patient finally filled her prescription after three weeks of calling different pharmacies. Yet another said her physician advised halving her regular dose until there was no longer a supply shortage.